๐ŸŒ EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

๐Ÿงช

Trial Match

Clinical trials test new treatments โ€” sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

๐ŸŽฏ Match trials to me

24 recruiting trials

for Uremia

A Self-Controlled Study on the Treatment of Restless Legs Syndrome in Uremia With Dipyridamole NCT07199504Phase 2, Phase 31 site๐Ÿ“ Chongqing Yunfeng Xia ยท Tests: Dipyridamole 50mg tid Post-Marketing Clinical Study of Ravulizumab in Participants With Clinical aHUS NCT07308574Phase 412 sites๐Ÿ“ Bunkyล City๐Ÿ“ Hirakata-shi๐Ÿ“ Iruma-Gun Alexion Pharmaceuticals, Inc. ยท Tests: Ravulizumab Evaluate Long-term Safety, Tolerability and Efficacy of Iptacopan in Study Participants With aHUS NCT05795140Phase 39 sites๐Ÿ“ Sรฃo Paulo๐Ÿ“ Rio de Janeiro๐Ÿ“ Beijing Novartis Pharmaceuticals ยท Tests: Iptcaopan 200 mg Hyperhydration in Children With Shiga Toxin-Producing E. Coli Infection NCT05219110NA26 sites๐Ÿ“ Birmingham๐Ÿ“ Little Rock๐Ÿ“ La Jolla University of Calgary ยท Tests: Infusion of 200% maintenance fluids as balanced crystalloid IV solution, Oral fluids; infusion of up to 110% maintenancโ€ฆ Collection of Human Samples to Study Hairy Cell and Other Leukemias, and to Develop Recombinant Immunotoxins for Cancer Treatment NCT01087333n/a1 site๐Ÿ“ Bethesda National Cancer Institute (NCI) Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford NCT01793168n/a2 sites๐Ÿ“ Sioux Falls๐Ÿ“ Sydney Sanford Health Efficacy and Safety of Switching From Anti-C5 Antibody Treatment to Iptacopan Treatment in Study Participants With Atypical Hemolytic Uremic Syndrome (aHUS) NCT05935215Phase 331 sites๐Ÿ“ Nanjing๐Ÿ“ Beijing๐Ÿ“ Beijing Novartis Pharmaceuticals ยท Tests: Iptacopan Developing a Pipeline to Employ RNA-Seq as a Complementary Diagnostic Tool in Rare Diseases NCT05996731NA1 site๐Ÿ“ Ranica Mario Negri Institute for Pharmacological Research ยท Tests: Skin biopsy Ravulizumab Outcomes in Polish Patients With aHUS NCT07399730n/a10 sites๐Ÿ“ Gdansk๐Ÿ“ Katowice๐Ÿ“ Katowice AstraZeneca ยท Tests: Ravulizumab Predictive Value of Carotid Ultrasonography for Intradialytic Hypotension NCT07033260n/a1 site๐Ÿ“ Wuhu First Affiliated Hospital of Wannan Medical College ยท Tests: Non-invasive Monitoring Anrikefon vs Nalfurafine for Sleep Quality in Hemodialysis Patients With CKD-aP NCT07380113Phase 41 site๐Ÿ“ Guangzhou Zhujiang Hospital ยท Tests: Anrikefon, Nalfurafine Atypical Hemolytic-Uremic Syndrome (aHUS) Registry NCT01522183n/a141 sites๐Ÿ“ Aurora๐Ÿ“ Washington D.C.๐Ÿ“ Gainesville Alexion Pharmaceuticals, Inc. Functional Implications of Rare Gene Mutations in aHUS Open the Door to Personalized Therapy NCT05805202NA1 site๐Ÿ“ Ranica Mario Negri Institute for Pharmacological Research ยท Tests: Blood sampling and urine analysis Multi-center Clinical Study on Hemoperfusion of KHA80 NCT06233838NA1 site๐Ÿ“ Fuzhou First Affiliated Hospital of Fujian Medical University ยท Tests: KHA80 hemoperfusion treatment Study of Ultomirisยฎ (Ravulizumab) Safety in Pregnancy NCT06312644n/a7 sites๐Ÿ“ Boston๐Ÿ“ Melbourne๐Ÿ“ Paris Alexion Pharmaceuticals, Inc. ยท Tests: Ultomiris The Effect of LIPUS on the Maturation of Newly Constructed Autogenous AVF NCT06249373NA1 site๐Ÿ“ Suzhou Suzhou Municipal Hospital ยท Tests: Low intensity pulse ultrasound ๏ผˆLIPUS๏ผ‰ intervention for arteriovenous fistula anastomosis Incremental Hemodialysis for Veterans in the First Year of Dialysis (IncHVets) NCT05465044NA8 sites๐Ÿ“ Long Beach๐Ÿ“ West Los Angeles๐Ÿ“ West Haven VA Office of Research and Development ยท Tests: Twice-weekly hemodialysis with incremental crossover to thrice-weekly schedule, Thrice-Weekly Hemodialysis Eculizumab in Hypertensive Emergency-associated Hemolytic Uremic Syndrome NCT05726916Phase 31 site๐Ÿ“ Paris Assistance Publique - Hรดpitaux de Paris ยท Tests: Solirisยฎ, Renin angiotensin system blockers Efficacy of INM004 in Children With STEC-HUS NCT06389474Phase 352 sites๐Ÿ“ Bahรญa Blanca๐Ÿ“ Bahรญa Blanca๐Ÿ“ La Plata Inmunova S.A. ยท Tests: INM004, Placebo Complement Prospective Evaluation of Thrombotic Microangiopathy on Endothelium NCT04745195n/a1 site๐Ÿ“ Maastricht Maastricht University Medical Center ICHARUS: Italian Cooperative HemoAdsorption Study for Relief of Uremic Symptoms NCT07522008n/a1 site๐Ÿ“ Cagliari Azienda Ospedaliera Brotzu Timing of Renal Replacement Therapy in the Critically Ill Patients NCT03629977n/a1 site๐Ÿ“ Stockholm Karolinska University Hospital ยท Tests: CRRT Studies on Adsorption International Learning Initiative Global NCT07123909NA1 site๐Ÿ“ Moscow Botkin Hospital ยท Tests: Patients will undergo a combined hemodialysis and hemosorption procedure. The study cartridge for hemosorption by Jafroโ€ฆ National Registry of Rare Kidney Diseases NCT06065852n/a1 site๐Ÿ“ Bristol UK Kidney Association
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy